Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2017

Open Access 01-12-2017 | Research Article

The importance of censoring in competing risks analysis of the subdistribution hazard

Authors: Mark W. Donoghoe, Val Gebski

Published in: BMC Medical Research Methodology | Issue 1/2017

Login to get access

Abstract

Background

The analysis of time-to-event data can be complicated by competing risks, which are events that alter the probability of, or completely preclude the occurrence of an event of interest. This is distinct from censoring, which merely prevents us from observing the time at which the event of interest occurs. However, the censoring distribution plays a vital role in the proportional subdistribution hazards model, a commonly used method for regression analysis of time-to-event data in the presence of competing risks.

Methods

We present the equations that underlie the proportional subdistribution hazards model to highlight the way in which the censoring distribution is included in its estimation via risk set weights. By simulating competing risk data under a proportional subdistribution hazards model with different patterns of censoring, we examine the properties of the estimates from such a model when the censoring distribution is misspecified. We use an example from stem cell transplantation in multiple myeloma to illustrate the issue in real data.

Results

Models that correctly specified the censoring distribution performed better than those that did not, giving lower bias and variance in the estimate of the subdistribution hazard ratio. In particular, when the covariate of interest does not affect the censoring distribution but is used in calculating risk set weights, estimates from the model based on these weights may not reflect the correct likelihood structure and therefore may have suboptimal performance.

Conclusions

The estimation of the censoring distribution can affect the accuracy and conclusions of a competing risks analysis, so it is important that this issue is considered carefully when analysing time-to-event data in the presence of competing risks.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kleinbaum DG, Klein M. Survival Analysis: A Self-Learning Text, 3rd edn. Statistics for Biology and Health. New York: Springer; 2012.CrossRef Kleinbaum DG, Klein M. Survival Analysis: A Self-Learning Text, 3rd edn. Statistics for Biology and Health. New York: Springer; 2012.CrossRef
3.
go back to reference Pintilie M. Competing Risks: A Practical Perspective. Chichester: Wiley; 2006.CrossRef Pintilie M. Competing Risks: A Practical Perspective. Chichester: Wiley; 2006.CrossRef
8.
go back to reference Aalen OO, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat. 1978; 5(3):141–50. Aalen OO, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat. 1978; 5(3):141–50.
11.
go back to reference Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94(446):496–509.CrossRef Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94(446):496–509.CrossRef
12.
go back to reference Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988; 16(3):1141–1154.CrossRef Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988; 16(3):1141–1154.CrossRef
13.
go back to reference Geskus RB. Data Analysis with Competing Risks and Intermediate States. Chapman & Hall/CRC Biostatistics Series. Boca Raton: CRC Press; 2016. Geskus RB. Data Analysis with Competing Risks and Intermediate States. Chapman & Hall/CRC Biostatistics Series. Boca Raton: CRC Press; 2016.
18.
go back to reference de Wreede LC, Fiocco M, Putter H. mstate: An R package for the analysis of competing risks and multi-state models. J Stat Softw. 2011; 38(7):1–30.CrossRef de Wreede LC, Fiocco M, Putter H. mstate: An R package for the analysis of competing risks and multi-state models. J Stat Softw. 2011; 38(7):1–30.CrossRef
20.
go back to reference Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, Marsh SGE, Guethlein LA, Parham P, Miller JS, Weisdorf DJ. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood. 2009; 113(3):726–32. doi:10.1182/blood-2008-07-171926.CrossRefPubMedPubMedCentral Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, Marsh SGE, Guethlein LA, Parham P, Miller JS, Weisdorf DJ. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood. 2009; 113(3):726–32. doi:10.​1182/​blood-2008-07-171926.CrossRefPubMedPubMedCentral
25.
go back to reference Delaney JAC, Oddson BE, McClelland RL, Psaty BM. Estimating ethnic differences in self-reported new use of antidepressant medications: results from the multi-ethnic study of atherosclerosis. Pharmacoepidemiol Drug Saf. 2009; 18(7):545–53. doi:10.1002/pds.1751.CrossRefPubMedPubMedCentral Delaney JAC, Oddson BE, McClelland RL, Psaty BM. Estimating ethnic differences in self-reported new use of antidepressant medications: results from the multi-ethnic study of atherosclerosis. Pharmacoepidemiol Drug Saf. 2009; 18(7):545–53. doi:10.​1002/​pds.​1751.CrossRefPubMedPubMedCentral
Metadata
Title
The importance of censoring in competing risks analysis of the subdistribution hazard
Authors
Mark W. Donoghoe
Val Gebski
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2017
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-017-0327-3

Other articles of this Issue 1/2017

BMC Medical Research Methodology 1/2017 Go to the issue